Free Trial

Steven Etoch Analyst Performance

Analyst at Stephens

Steven Etoch is a stock analyst at Stephens in the medical sector, covering 4 publicly traded companies. Over the past year, Steven Etoch has issued 5 stock ratings, including buy and hold recommendations. While full access to Steven Etoch's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Steven Etoch's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
5 Last 0 Years
Buy Recommendations
80.00% 4 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy80.0%4 ratings
Hold20.0%1 ratings
Sell0.0%0 ratings

Out of 5 total stock ratings issued by Steven Etoch at Stephens, the majority (80.0%) have been Buy recommendations, followed by 20.0% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
75.0% of companies on NASDAQ
3 companies
NYSE
25.0% of companies on NYSE
1 company

Steven Etoch, an analyst at Stephens, currently covers 4 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
4 companies
100.0%

Steven Etoch of Stephens specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
2 companies
50.0%
MED/DENTAL - SUPP
1 company
25.0%
MED PRODUCTS
1 company
25.0%

Steven Etoch's Ratings History at Stephens

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
6/2/2026Reiterated Rating$315.87$360.00Overweight
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
11/12/2025Lower Price Target$2.46$3.00Equal Weight
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
11/3/2025Initiated Coverage$31.57$41.00Overweight
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
11/3/2025Initiated Coverage$30.06$41.00Overweight
Repligen Corporation stock logo
RGEN
Repligen
7/22/2025Upgrade$113.95$160.00Overweight